| Literature DB >> 32952723 |
Alexander N Reznikov1, Dmitry S Nikerov1, Anastasiya E Sibiryakova1, Victor B Rybakov2, Evgeniy V Golovin1, Yuri N Klimochkin1.
Abstract
A new synthetic strategy toward nonracemic phosphoryl-substituted pyrrolidines and tetrahydropyranes with three and five contiguous stereocenters is presented. Readily available β-keto phosphonates react with conjugated nitroolefins in the presence of a chiral Ni(II) complex to give nitro keto phosphonates with two stereocenters with excellent enantioselectivity and moderate to high diastereoselectivity. These products were used for a reductive cyclization leading to pyrrolidin-3-ylphosphonic acid and for reactions with aldehydes yielding tetrahydropyranylphosphonates as individual stereoisomers. These nonracemic heterocycles containing phosphoryl moieties are useful for designing new pharmacologically active compounds.Entities:
Keywords: Michael addition; asymmetric catalysis; phosphonates; pyrrolidines; tetrahydropyranes
Year: 2020 PMID: 32952723 PMCID: PMC7476589 DOI: 10.3762/bjoc.16.174
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Pharmacologically active nonracemic phosphonates with heterocyclic moieties.
Figure 2Starting nonracemic 4-nitro-2-oxophosphonates.
Scheme 1Intermolecular N-methylation of reduction product 7.
Scheme 2Synthesis of pyrrolidinyl phosphonic acids 11a–d.
Figure 3ORTEP diagram of (2R,3R,4S)-10a.
Optimization of the conditions of Henry/acetalyzation reaction with phosphonate 6ea.
| Entry | Base | Phase transfer catalyst | Solvent | Yield of | drb |
| 1 | PhNMe2 | – | THF | 0 | – |
| 2 | Et3N | – | THF | 0c | – |
| 3 | DBU | – | THF | 0c | – |
| 4 | K3PO4 | TEBAC | THF | 0 | – |
| 5 | K2CO3 | TEBAC | THF | 0 | – |
| 6 | KF | TEBAC | THF | 0c | – |
| 7 | Cs2CO3 | – | THF | 0c | – |
| 8 | K2CO3 | TEBAC | THF/H2O 1:1 | 0c | – |
| 9 | K2CO3 | TEBAC | THF/H2O 7.5:1 | 34 | 1:0 |
| 10 | K2CO3 | 18-crown-6 | CH3CN | 30 | 11:1 |
| 11 | K2CO3 | 18-crown-6 | THF | 17 | 16:1 |
| 12 | K2CO3 | 18-crown-6 | CH2Cl2 | 12 | 10:1 |
aReaction conditions: phosphonate 6e (1.58 mmol), aldehyde 12a (15.8 mmol), solvent (17 mL), base (1.58 mmol), phase transfer catalyst (0.158 mmol), rt, 72 h; bdetermined by 31P NMR; cfull phosphonate 6e conversion was observed and unidentified products were formed.
Scheme 3Synthesis of tetrahydropyranylphosphonates 13a–f via diastereoselective Henry/acetalyzation reaction.
Figure 4ORTEP diagram of (2S,3R,4S,5S,6R)-13b.
Scheme 4Synthesis of (3,4-dihydro-2H-pyran-5-yl)phosphonate 14.